Business Description
Alpha Tau Medical Ltd
ISIN : IL0011839383
Total Employee Number:
121Description
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 6.64 | |||||
Equity-to-Asset | 0.33 | |||||
Debt-to-Equity | 0.34 | |||||
Debt-to-EBITDA | -0.17 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 0.5 | |||||
3-Year EPS without NRI Growth Rate | -0.4 | |||||
3-Year FCF Growth Rate | -1.3 | |||||
3-Year Book Growth Rate | -16.9 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 33.17 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 70.81 | |||||
9-Day RSI | 66.67 | |||||
14-Day RSI | 63.82 | |||||
3-1 Month Momentum % | 26.87 | |||||
6-1 Month Momentum % | 87.15 | |||||
12-1 Month Momentum % | 334.29 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 11.09 | |||||
Quick Ratio | 11.09 | |||||
Cash Ratio | 10.45 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -8.4 | |||||
Shareholder Yield % | -0.11 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -130.49 | |||||
ROA % | -82.02 | |||||
ROIC % | -176.89 | |||||
3-Year ROIIC % | -67.86 | |||||
ROC (Joel Greenblatt) % | -347.14 | |||||
ROCE % | -89.11 | |||||
Moat Score | 4 | |||||
Tariff Resilience Score | 7 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 30.42 | |||||
Price-to-Tangible-Book | 30.42 | |||||
EV-to-EBIT | -13.74 | |||||
EV-to-EBITDA | -13.74 | |||||
EV-to-FCF | -38.61 | |||||
| Price-to-Net-Current-Asset-Value | 81.11 | |||||
| Price-to-Net-Cash | 132.73 | |||||
Earnings Yield (Greenblatt) % | -7.28 | |||||
FCF Yield % | -2.43 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:DRTS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Alpha Tau Medical Ltd Executives
DetailsGF Value™
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -1.04 | ||
| Beta | 1.1615 | ||
| 3-Year Sharpe Ratio | 0.86 | ||
| 3-Year Sortino Ratio | 1.77 | ||
| Volatility % | 58.58 | ||
| 14-Day RSI | 63.82 | ||
| 14-Day ATR ($) | 0.780519 | ||
| 20-Day SMA ($) | 13.104 | ||
| 12-1 Month Momentum % | 334.29 | ||
| 52-Week Range ($) | 3.03 - 14.75 | ||
| Shares Outstanding (Mil) | 92.48 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Alpha Tau Medical Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Alpha Tau Medical Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-20 | In 92 days | ||
| Second quarter earnings results for 2026 | 2026-08-10 | 13.14 (-0.83%) | ||
| General meeting for 2025 | 2026-06-23 16:00 | 10.03 (+3.51%) | ||
| First quarter earnings results for 2026 | 2026-05-18 | 10.36 (+0.93%) | ||
| Alpha Tau – Interim Results Conference Call | 2026-05-11 08:30 | 8.51 (+8.82%) | ||
| Sidoti Virtual Small Cap Conference | 2026-03-18 10:00 | 7.47 (+2.33%) | ||
| Annual report for 2025 | 2026-03-09 | 6.41 (-8.17%) | ||
| Fourth quarter earnings results for 2025 | 2026-03-09 | 6.41 (-8.17%) | ||
| Guidance call for 2026 | 2026-01-15 14:15 | 7.50 (+10.13%) | ||
| Sidoti\'s Year End Virtual Investor Conference | 2025-12-10 11:30 | 4.23 (+5.75%) |
Show
Entries
Alpha Tau Medical Ltd Frequently Asked Questions
What is Alpha Tau Medical Ltd(DRTS)'s stock price today?
The current price of DRTS is $14.60. The 52 week high of DRTS is $14.75 and 52 week low is $3.03.
When is next earnings date of Alpha Tau Medical Ltd(DRTS)?
The next earnings date of Alpha Tau Medical Ltd(DRTS) is 2026-11-20 Est..
Does Alpha Tau Medical Ltd(DRTS) pay dividends? If so, how much?
Alpha Tau Medical Ltd(DRTS) does not pay dividend.
Guru Commentaries on NAS:DRTS
No articles.
Press Release
Articles on Alpha Tau Medical Ltd
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers